Edward White

Stock Analyst at HC Wainwright & Co.

(0)
# 4337
Out of 5,240 analysts
471
Total ratings
27.91%
Success rate
-10.40%
Average return
46 Stocks
Name Action Price Target Current % Upside Ratings Updated
TG Therapeutics
Reiterates: Buy
55 55
29.73 85% 30 Jan 15, 2025
Karyopharm Therapeut...
Reiterates: Buy
7 7
0.64 993.75% 26 Jan 15, 2025
Dynavax Technologies
Maintains: Strong Buy
29 31
12.47 148.6% 20 Jan 14, 2025
Inozyme Pharma
Maintains: Strong Buy
14 16
1.5 966.67% 12 Jan 13, 2025
60 Degrees
Reiterates: Neutral
n/a
n/a n/a 9 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
4 4
0.51 684.31% 5 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
11 11
3.37 226.41% 16 Dec 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
6.97 186.94% 1 Dec 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
3.08 127.27% 19 Dec 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8 8
2.34 241.88% 22 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 20 Dec 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
15 15
3.29 355.93% 5 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
17 17
9.32 82.4% 13 Dec 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
3.21 523.05% 17 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
51 51
12.61 304.44% 28 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
22 22
7.56 191.01% 4 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 11 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
5 5
n/a n/a 15 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
28 28
10.01 179.72% 21 Oct 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 5
2.67 87.27% 9 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
23 20
4.39 355.58% 30 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
6 6
3.57 68.07% 13 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 12 Jul 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 3
n/a n/a 13 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 12 Jun 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 9 May 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
25
n/a n/a 7 Mar 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Feb 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
101 52
n/a n/a 4 Aug 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 20
2.11 847.87% 4 Jun 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 10 May 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Mar 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Nov 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
168 180
n/a n/a 7 Sep 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
28
0.64 4275% 3 Aug 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
34 30
22.73 31.98% 5 Aug 11, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
251 247
n/a n/a 14 Aug 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 15
n/a n/a 5 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
13 20
n/a n/a 1 Dec 10, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 26, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
12
1.25 860% 2 Mar 6, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
158
n/a n/a 3 Oct 12, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
10
n/a n/a 1 May 24, 2017